Related Research Articles
Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and fatigue.
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located at the Texas Medical Center in Houston. It is affiliated with The University of Texas Health Science Center at Houston. According to Newsweek, MD Anderson Cancer Center is considered the best hospital in the world for oncology and related cancer treatment.
Hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome is an autosomal dominant genetic condition that is associated with a high risk of colon cancer as well as other cancers including endometrial cancer, ovary, stomach, small intestine, hepatobiliary tract, upper urinary tract, brain, and skin. The increased risk for these cancers is due to inherited mutations that impair DNA mismatch repair. It is a type of cancer syndrome. Because patients with Lynch syndrome can have polyps, the term HNPCC has fallen out of favor.
A stool test involves the collection and analysis of fecal matter to diagnose the presence or absence of a medical condition. Microbial analysis (culturing), microscopy and chemical tests are among tests done on stool samples.
Kathy Giusti is an American business leader who is recognized as a healthcare disrupter. She is a cancer patient and is the Founder and Chief Mission Officer of the Multiple Myeloma Research Foundation. She co-chairs the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, which she helped found, as a Senior Fellow at Harvard Business School.
A cancer survivor is a person with cancer of any type who is still living. Whether a person becomes a survivor at the time of diagnosis or after completing treatment, whether people who are actively dying are considered survivors, and whether healthy friends and family members of the cancer patient are also considered survivors, varies from group to group. Some people who have been diagnosed with cancer reject the term survivor or disagree with some definitions of it.
Vancouver General Hospital is a medical facility located in Vancouver, British Columbia. It is the largest facility in the Vancouver Hospital and Health Sciences Centre (VHHSC) group of medical facilities. VGH is Canada's third largest hospital by bed count, after Hamilton General Hospital, and Foothills Medical Centre.
Patient advocacy is a process in health care concerned with advocacy for patients, survivors, and caregivers. The patient advocate may be an individual or an organization, often, though not always, concerned with one specific group of disorders. The terms patient advocate and patient advocacy can refer both to individual advocates providing services that organizations also provide, and to organizations whose functions extend to individual patients. Some patient advocates work for the institutions that are directly responsible for the patient's care.
Martin T. Schechter is a Canadian epidemiologist recognized for contributions to research about HIV prevention and treatments, addiction research, and Indigenous health research. He is a professor and was the founding director of the School of Population and Public Health in the Faculty of Medicine at the University of British Columbia (UBC). Schechter received his Order of British Columbia in 1994 alongside BC's first Nobel Prize laureate Michael Smith and noted Indigenous artist Bill Reid. In 2022, Schechter was named as a Member of the Order of Canada.
Inspire is an Arlington, Virginia-based healthcare social network. It builds and manages online health communities for patients and caregivers, and connects patients to life science companies for the purpose of research.
Nancy Baxter is a Canadian surgeon and public health researcher. She is the Head of Melbourne University's School of Population and Global Health, while continues to maintain her appointment as Professor of Surgery in the Department of Surgery and the Institute of Health Policy, Management and Evaluation at the University of Toronto. She is a scientist with the Li Ka Shing Knowledge Institute and is a Senior Scientist in the Cancer Theme Group with the Institute for Clinical Evaluative Sciences (ICES). Baxter has achieved board certifications through the American Board of Surgery (2000) and the American Board of Colon and Rectal Surgery (2002). She is a Fellow of both the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada.
Nadine Rena Caron FACS, FRCSC,, is a Canadian surgeon. She is the first Canadian female general surgeon of First Nations descent (Ojibway), as well as the first female First Nations student to graduate from University of British Columbia's medical school.
Artificial intelligence in healthcare is an overarching term used to describe the use of machine-learning algorithms and software, or artificial intelligence (AI), to mimic human cognition in the analysis, presentation, and comprehension of complex medical and health care data. Specifically, AI is the ability of computer algorithms to approximate conclusions based solely on input data.
Philip F. Cohen is a Canadian clinical director of Nuclear Medicine working out of the Lions Gate Hospital in North Vancouver, British Columbia. As a nuclear medicine physician, he is a pioneer in the usage of 3-D imaging techniques to improve diagnosis of bone disease and injury in collaboration with the Medical Imaging Research Group at University of British Columbia. Furthermore, Cohen has been involved in clinical research trials of new radiopharmaceuticals. To that effect, Cohen was the first recipient of a research grant from the Lions Gate Hospital Foundation, one of several peer-reviewed awards that would follow.
Cancer in adolescents and young adults is cancer which occurs in those between the ages of 15 and 39. This occurs in about 70,000 people a year in the United States—accounting for about 5 percent of cancers. This is about six times the number of cancers diagnosed in children ages 0–14. Globally, nearly 1 million young adults between the ages of 20 and 39 were diagnosed with cancer in 2012, and more than 350,000 people in this age range died from cancer.
Patricia Anne Ganz is an American medical oncologist. She is a professor of health policy and management in the Fielding School of Public Health and a professor of medicine in the David Geffen School of Medicine at UCLA. In 2007, she was elected to the Institute of Medicine.
Janice Jennifer Eng is a professor in the University of British Columbia's Department of Physical Therapy and Canada Research Chair in Neurological Rehabilitation.
Amina Zoubeidi is a Canadian research scientist and urologist. She's a scientist at the Vancouver Coastal Health Research Institute and an associate professor in the Department of Urologic Sciences at the University of British Columbia. During her tenure at UBC, Zoubeidi and her research team developed the first drug that targets and blocks BRN2, thus stopping Neuroendocrine prostate cancer (NEPC) tumours and creating a possible treatment for the previously thought incurable disease.
Helen M. Burt is a British-Canadian pharmaceutical scientist who is the Angiotech Professor of Drug Delivery at the University of British Columbia. She serves as Associate Vice President of Research and Innovation at UBC. Her research considers novel therapeutics based on nanotechnology, including drug delivery systems for the treatment of bladder cancer and coronary artery disease.
Raymond Javan Chan is an Australian oncology nurse, clinical trialist, researcher, and senior administrator. He is Matthew Flinders Professor of Cancer Nursing, NHMRC Investigator Fellow, and Director of the Caring Futures Institute within the College of Nursing and Health Sciences, Flinders University. He also holds academic titles as NHMRC Investigator Fellow and Matthew Flinders Fellow.
References
- 1 2 "Mary De Vera". Arthritis Research Canada. Retrieved 30 April 2020.
- ↑ "MARY DE VERA, FACULTY OF PHARMACEUTICAL SCIENCES PROFILED AS A WOMAN LEADER IN STEM". University of British Columbia. Retrieved 30 April 2020.
- 1 2 "UBC researcher Mary De Vera tackles cancer that caused her grief". Canadian Filipino Net. January 16, 2019. Retrieved 30 April 2020.
- 1 2 3 Bailey, Ian (January 6, 2019). "B.C. researcher Mary De Vera takes on the cancer she was treated for". The Globe and Mail. Retrieved 30 April 2020.
- ↑ "The patient researcher: a scientist's cancer diagnosis changes her life's work". CBC. October 25, 2019. Retrieved 30 April 2020.
- ↑ Fletcher, Tom (March 15, 2019). "Colorectal cancer researcher needs more B.C. survivors". The Chilliwack Progress. Retrieved 30 April 2020.
